Vaccine Therapy Plus Interleukin-2 With or Without Interferon Alfa-2b in Treating Patients With Stage III Melanoma
Clinical trial NCT00004104 · COMPLETED
Trial details
- NCT number
- NCT00004104
- Sponsor
- NYU Langone Health
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1998-06-01
- Primary completion
- 2000-07-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.